 Cholangiocarcinoma
"Cholangiocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant tumor arising from the epithelium of the BILE DUCTS.
| Descriptor ID |
D018281
|
| MeSH Number(s) |
C04.557.470.200.025.450
|
| Concept/Terms |
Cholangiocarcinoma- Cholangiocarcinoma
- Cholangiocarcinomas
- Cholangiocellular Carcinoma
- Carcinoma, Cholangiocellular
- Carcinomas, Cholangiocellular
- Cholangiocellular Carcinomas
Extrahepatic Cholangiocarcinoma- Extrahepatic Cholangiocarcinoma
- Cholangiocarcinoma, Extrahepatic
- Cholangiocarcinomas, Extrahepatic
- Extrahepatic Cholangiocarcinomas
Intrahepatic Cholangiocarcinoma- Intrahepatic Cholangiocarcinoma
- Cholangiocarcinoma, Intrahepatic
- Cholangiocarcinomas, Intrahepatic
- Intrahepatic Cholangiocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Cholangiocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Cholangiocarcinoma".
This graph shows the total number of publications written about "Cholangiocarcinoma" by people in this website by year, and whether "Cholangiocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2006 | 1 | 2 | 3 | | 2008 | 2 | 0 | 2 | | 2009 | 1 | 0 | 1 | | 2010 | 0 | 1 | 1 | | 2011 | 1 | 1 | 2 | | 2012 | 2 | 1 | 3 | | 2013 | 9 | 1 | 10 | | 2014 | 4 | 0 | 4 | | 2015 | 2 | 0 | 2 | | 2016 | 1 | 3 | 4 | | 2018 | 5 | 0 | 5 | | 2019 | 2 | 0 | 2 | | 2020 | 2 | 0 | 2 | | 2021 | 6 | 0 | 6 | | 2022 | 1 | 0 | 1 | | 2023 | 10 | 0 | 10 | | 2024 | 10 | 2 | 12 | | 2025 | 15 | 1 | 16 | | 2026 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholangiocarcinoma" by people in Profiles.
-
Yuza K, Chatzipanagiotou OP, Hobeika C, Aucejo F, Marques HP, Hugh T, Shen F, Maithel SK, Groot Koerkamp B, Popescu I, Weiss MJ, Martel G, Pulitano C, Poultsides G, Ruzzenente A, Bauer TW, Gleisner A, Endo I, Pawlik TM. Metastatic lymph node burden and invasive tumour features inform first recurrence patterns after curative-intent resection for intrahepatic cholangiocarcinoma. Br J Surg. 2026 Jul 02; 113(7).
-
Huang Y, Santoni G, Sparrelid E, Xie SH. Metformin use and the risk of liver cancer in a Swedish population-based cohort study. JNCI Cancer Spectr. 2026 May 09; 10(3).
-
Baldo A, Akabane M, Kawashima J, Endo Y, Chatzipanagiotou OP, Sahara K, Ruzzenente A, Lesurtel M, Bauer TW, Marques HP, Martel G, Popescu I, Weiss MJ, Kitago M, Poultsides G, Sasaki K, Maithel SK, Hugh T, Gleisner A, Aucejo F, Pulitano C, Shen F, Koerkamp BG, Endo I, Spolverato G, Pawlik TM. Risk-adjusted cumulative sum (RA-CUSUM) method for real time monitoring of surgical units performance. HPB (Oxford). 2026 Jul; 28(7):987-995.
-
Yuza K, Kawashima J, Chatzipanagiotou OP, Hobeika C, Aucejo F, Marques HP, Hugh T, Shen F, Maithel SK, Koerkamp BG, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Poultsides G, Ruzzenente A, Bauer TW, Gleisner A, Endo I, Pawlik TM. Biologic stratification with tumor burden score and CA19-9 to inform vascular resection in intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2026 May; 52(5):111750.
-
Malavia M, Eliason G, Eggers LA, Arne A, Marchak K, Hart J, Lindquist J, Trivedi P, Casadaban L. Yttrium-90 radioembolization for primary and metastatic liver tumors exhibiting arterial-phase hypovascularity. Sci Rep. 2026 Jan 15; 16(1):4588.
-
Jansson H, Taflin H, Björnsson B, Urdzik J, Hemmingsson O, Rystedt JL, Gilg S, Sandström P, Sparrelid E. Outcomes After Resection for Multiple Intrahepatic Cholangiocarcinoma-A National Population-Based Study. Ann Surg Oncol. 2026 Apr; 33(4):2917-2925.
-
Javle M, Fountzilas C, Liao CY, Pelster M, Li D, Deming D, Sahai V, Fonkoua LK, Cohn A, Mantry P, Richards D, Kingsley E, Wu F, Peng P, Hennessy K, Wang H, Sun C, Ni S, Fan J, Mahipal A. Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2026 Feb; 11(2):137-149.
-
El Homsi M, Hassan OT, O'Brien C, Singh C, Arif-Tiwari H, Becker-Weidman DJ, Karolyi D, Bonde A, Venkatesh SK, Brunsing RL, Cunha GM, Miller FH, Costello J, Qayyum A, Marks RM. Standardized reporting of extrahepatic cholangiocarcinoma. Abdom Radiol (NY). 2026 04; 51(4):1907-1919.
-
Benson AB, D'Angelica MI, Abrams T, Ahmed A, Akce M, Anaya DA, Anders R, Are C, Aye L, Bachini M, Baker M, Binder D, Brown DB, Burgoyne A, Castellanos J, Cloyd J, Cullinan D, Franses J, Glazer ES, Harris W, Iyer R, Jennings L, Kelley RK, Khan S, Levine M, Melstrom L, Palta M, Raman S, Ronnekleiv-Kelly S, Sahai V, Stein S, Stephans K, Thanikachalam K, Turk A, Vauthey JN, Venook AP, Yano M, Yopp A, Zhao K, Schonfeld R, Hochstetler C. Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 09; 23(9):403-418.
-
Tagayasu Y, Yamada R, Kanemitsu K, Kondo Y, Fujiwara Y, Tanizaki T, Itoyama R, Kitano Y, Hayashi H, Komohara Y, Iwatsuki M. Increased Infiltration of Tissue-Resident Memory T Cells Predicts a Good Response to Anti-PD-L1 Immunotherapy in Extrahepatic Cholangiocarcinoma. Pathobiology. 2026; 93(1):1-11.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|